While there is no significant difference in the risk of all-cause mortality or disabling stroke in midterm follow-up of the Evolut Low Risk trial, new findings with the self-expanding bioprosthesis ...

In business, as in life, it’s easy to make commitments. It’s harder—and far more powerful—to stake your success on delivering them. That’s the essence of going at-risk: tying your compensation ...

Growing evidence suggests that lifestyle interventions such as walking may help slow cognitive decline in individuals with the apolipoprotein E (APOE) ε4 allele, who have a genetically higher risk of ...

FIB-4 score data were available for 16,585 patients (94.2% of the total SELECT population). All patients were stratified according to FIB-4 score for their predicted risk of substantial liver fibrosis ...